CIOMS' Placebo Rule and the Promotion of Negligent Medical Practice

CIOMS' Placebo Rule and the Promotion of Negligent Medical Practice European Journal of Health Law 11 : 153-174, 2004. 153 © 2004 Koninklijke Brill N.V. Printed in the Netherlands CIOMS’ Placebo Rule and the Promotion of Negligent Medical Practice TRUDO LEMMENS, DOMINIQUE SPRUMONT, HERMAN NYS, JEROME SINGH & KATHLEEN CRANLEY GLASS * Introduction In research ethics, few ethical issues are more hotly debated than the use of placebo controls in clinical trials. Most commentators agree that these trials are acceptable when aimed at testing a new treatment for a disease for which no treatment is currently available. They are, however, deeply divided about the appropriateness of placebo-controlled trials involving patients when an effective treatment already exists for their conditions. Opponents of these trials have invoked the ethical significance of the notion of clinical equipoise, 1 or more generally the ethical and legal duties of clinical investigators towards patients, 2 while proponents have emphasized the role of individual liberty and informed consent to support a more flexible use of placebo controls. 3 The moral arguments on both sides are to some extent irreconcilable, since they reflect fundamentally different premises about the obligations of physician/ researchers and the meaning and limits of individual liberty. Not surprisingly, substantive arguments have often http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Health Law Brill

CIOMS' Placebo Rule and the Promotion of Negligent Medical Practice

Loading next page...
 
/lp/brill/cioms-placebo-rule-and-the-promotion-of-negligent-medical-practice-NfuBvTCiyK
Publisher
Brill
Copyright
© 2004 Koninklijke Brill NV, Leiden, The Netherlands
ISSN
0929-0273
eISSN
1571-8093
D.O.I.
10.1163/1571809041457459
Publisher site
See Article on Publisher Site

Abstract

European Journal of Health Law 11 : 153-174, 2004. 153 © 2004 Koninklijke Brill N.V. Printed in the Netherlands CIOMS’ Placebo Rule and the Promotion of Negligent Medical Practice TRUDO LEMMENS, DOMINIQUE SPRUMONT, HERMAN NYS, JEROME SINGH & KATHLEEN CRANLEY GLASS * Introduction In research ethics, few ethical issues are more hotly debated than the use of placebo controls in clinical trials. Most commentators agree that these trials are acceptable when aimed at testing a new treatment for a disease for which no treatment is currently available. They are, however, deeply divided about the appropriateness of placebo-controlled trials involving patients when an effective treatment already exists for their conditions. Opponents of these trials have invoked the ethical significance of the notion of clinical equipoise, 1 or more generally the ethical and legal duties of clinical investigators towards patients, 2 while proponents have emphasized the role of individual liberty and informed consent to support a more flexible use of placebo controls. 3 The moral arguments on both sides are to some extent irreconcilable, since they reflect fundamentally different premises about the obligations of physician/ researchers and the meaning and limits of individual liberty. Not surprisingly, substantive arguments have often

Journal

European Journal of Health LawBrill

Published: Jan 1, 2004

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off